ATLANTA--(BUSINESS WIRE)--
Holzer & Holzer, LLC is investigating whether certain statements issued during 2015 by Dr. Reddy’s Laboratories Limited (“Dr. Reddy’s” or the “Company”) (NYSE: RDY) complied with federal securities laws. In November, 2015, Dr. Reddy’s announced it had received a warning letter from the Food and Drug Administration concerning three of its manufacturing facilities.
If you purchased RDY American Depository Receipts before November 9, 2015 and wish to learn more about this investigation, you are encouraged to contact Corey D. Holzer, Esq. at [email protected] or Marshall P. Dees, Esq., at [email protected], or speak with them via toll-free telephone at (888) 508-6832.
Holzer & Holzer, LLC is an Atlanta, Georgia law firm that dedicates its practice to vigorous representation of shareholders and investors in litigation nationwide, including shareholder class action and derivative litigation. More information about the firm is available through its website, www.holzerlaw.com and upon request from the firm. Holzer & Holzer, LLC has paid for the dissemination of this promotional communication, and Corey D. Holzer is the attorney responsible for its content.
View source version on businesswire.com: http://www.businesswire.com/news/home/20170124005337/en/
